Delivery Order SPE2DR25D1100-SPE2DR26FCS4H
- Not listed
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of December 8, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $4,376.89 with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,391.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award was issued on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a $1,296 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price contract with an ultimate completion date of October 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,149.00 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was competitively awarded. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $2,272.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages, valued at $1,301.87, with an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract is a firm fixed price delivery order, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The award was executed on November 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,203.09 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract represents a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and supports the...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS4HDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5g packages, with a ceiling value of $1,296.00. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order under a larger contract vehicle and requires the pharmaceutical distributor to deliver the hormone treatment to support federal medical procurement needs. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen maintains a comprehensive portfolio of federal medical supply contracts with the Defense Logistics Agency, supplying a broad range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/1/25 |